Workflow
海王生物(000078) - 2015 Q1 - 季度财报
NEPTUNUSNEPTUNUS(SZ:000078)2015-04-27 16:00

Financial Performance - The company's operating revenue for Q1 2015 was ¥2,673,635,927.74, representing a 16.30% increase compared to ¥2,298,863,210.16 in the same period last year[7]. - Net profit attributable to shareholders was ¥27,548,160.34, a 2.93% increase from ¥26,764,611.53 year-on-year[7]. - The net profit after deducting non-recurring gains and losses decreased by 3.83% to ¥25,475,948.12 from ¥26,490,572.53 in the previous year[7]. - The net cash flow from operating activities was negative at ¥400,158,845.84, a decline of 36.02% compared to a negative cash flow of ¥294,193,326.81 in the same period last year[7]. Assets and Shareholder Information - Total assets at the end of the reporting period reached ¥10,944,882,438.16, marking a 13.63% increase from ¥9,631,706,545.91 at the end of the previous year[7]. - The net assets attributable to shareholders increased by 2.00% to ¥1,466,665,343.71 from ¥1,437,947,435.49 at the end of the previous year[7]. - The weighted average return on net assets rose by 0.16 percentage points to 1.90% compared to 1.74% in the previous year[7]. - The total number of ordinary shareholders at the end of the reporting period was 124,805[11]. - The largest shareholder, Shenzhen Haiwang Group Co., Ltd., held 24.66% of the shares, amounting to 180,455,603 shares[11]. Operational Changes and Strategies - No significant new strategies, product launches, or market expansions were reported during the quarter[14]. Changes in Assets and Liabilities - Other current assets increased by 40.56% compared to the beginning of the period, mainly due to increased bill financing costs[15]. - Construction in progress increased by 35.97% compared to the beginning of the period, primarily due to increased investment in logistics park construction[15]. - Advance receipts increased by 132.50% compared to the beginning of the period, driven by growth in sales scale and increased customer prepayments[15]. - Interest payable decreased by 40.33% compared to the beginning of the period, mainly due to repayment of part of short-term loans and corresponding interest expenses[15]. - Deferred income tax liabilities increased by 1,035.11% compared to the beginning of the period, primarily due to changes in the fair value of available-for-sale financial assets[15]. - Other comprehensive income increased by 167.79% compared to the beginning of the period, mainly due to changes in the fair value of available-for-sale financial assets[15]. - Operating tax and surcharges increased by 30.25% year-on-year, primarily due to growth in sales scale[15]. - Investment income increased by 94.36% year-on-year, mainly due to negative returns from the disposal of available-for-sale financial assets in the previous period[15]. - Net cash flow from operating activities decreased by 36.02% year-on-year, mainly due to increased procurement volume from larger sales scale and new receivables not yet reaching credit terms[15]. - Net cash flow from financing activities increased by 226.12% year-on-year, primarily due to increased financing efforts and scale[15]. Shareholdings and Investments - The company holds 494,287 shares of Shenxin Taifeng, representing 0.13% of total shares, with a book value of 4,630,481 CNY[21]. - The company acquired 21,184 shares of Haiwang Biological, with a book value of 277,934 CNY, prior to the merger with Haiwang Food[22]. - The company did not hold any other listed company shares during the reporting period[23]. - There were no derivative investments during the reporting period[24]. Investor Communication - The company engaged in communication with social investors regarding operational conditions from January 1 to March 31, 2015[25].